Welcome To M-Tubulin

  • Phone : 615.386.7000
  • 40 Burton Hills Blvd, Suite 200, Nashville, TN 37215

A New Class of Therapeutics for Multiple Tumor Types

A new dual targeting small molecule for the treatment of multiple tumors with selective tumor growth inhibition and activation of cell programmed cell death, all the while acting on two primary cancer drug resistance domains.
Science Icon (150 x 150 px)

Science

Based on the cancer research of Dr. Peter Crooks and vetted by proprietary Artificial Intelligence based platforms

Molecule

Botanically based  with known and tested safety profiles, patent protected, synthesized and tested

treatment Icon (150 x 150 px)

Therapeutic Targets

Broad applicability toward multiple tumor types affecting both pediatric and adult malignancies as per National Cancer Institute testing